Amalgamated Bank Sells 313 Shares of Chemed Co. (NYSE:CHE)

Amalgamated Bank reduced its holdings in Chemed Co. (NYSE:CHE) by 2.9% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,368 shares of the company’s stock after selling 313 shares during the quarter. Amalgamated Bank owned 0.07% of Chemed worth $6,063,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of CHE. Wealth Alliance raised its stake in Chemed by 3.0% in the fourth quarter. Wealth Alliance now owns 578 shares of the company’s stock valued at $338,000 after purchasing an additional 17 shares in the last quarter. Fifth Third Bancorp lifted its holdings in shares of Chemed by 0.5% during the 3rd quarter. Fifth Third Bancorp now owns 3,914 shares of the company’s stock worth $2,034,000 after acquiring an additional 21 shares during the last quarter. Legacy Wealth Asset Management LLC increased its stake in Chemed by 0.9% in the fourth quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company’s stock valued at $1,330,000 after acquiring an additional 21 shares during the last quarter. Signaturefd LLC raised its position in Chemed by 5.8% during the fourth quarter. Signaturefd LLC now owns 385 shares of the company’s stock valued at $225,000 after purchasing an additional 21 shares in the last quarter. Finally, Kestra Advisory Services LLC lifted its stake in Chemed by 3.8% during the third quarter. Kestra Advisory Services LLC now owns 634 shares of the company’s stock worth $329,000 after purchasing an additional 23 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In related news, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the transaction, the executive vice president now owns 20,760 shares in the company, valued at $13,320,654. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the transaction, the vice president now owns 1,422 shares in the company, valued at $917,190. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the sale, the executive vice president now directly owns 20,760 shares in the company, valued at $13,320,654. The disclosure for this sale can be found here. Insiders sold 15,808 shares of company stock valued at $10,184,531 in the last 90 days. Insiders own 3.32% of the company’s stock.

Chemed Stock Performance

NYSE:CHE opened at $561.65 on Monday. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62. The firm has a market cap of $8.50 billion, a PE ratio of 30.23, a price-to-earnings-growth ratio of 2.29 and a beta of 0.46. The business has a 50 day moving average price of $620.66 and a 200-day moving average price of $593.70.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share for the quarter, missing the consensus estimate of $5.09 by ($0.41). Chemed had a net margin of 12.36% and a return on equity of 30.52%. The firm had revenue of $589.23 million for the quarter, compared to analysts’ expectations of $587.18 million. Research analysts predict that Chemed Co. will post 21.72 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend was Friday, February 23rd. Chemed’s payout ratio is 8.61%.

Wall Street Analyst Weigh In

CHE has been the subject of a number of recent research reports. Royal Bank of Canada boosted their target price on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a research report on Monday, March 4th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Oppenheimer raised their price objective on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.